Inhibition of Fibrillation and Toxicity with -Asarone |
Kim, Jia
(School of Korean Medicine, Pusan National University)
Lee, Chul Won (School of Korean Medicine, Pusan National University) Lee, Boo Kyun (School of Korean Medicine, Pusan National University) Lee, Jang Cheon (School of Korean Medicine, Pusan National University) An, Won Gun (School of Korean Medicine, Pusan National University) |
1 | Geng, Y., Li, C., Liu, J., Xing, G., Zhou, L., Dong, M., Li, X., Niu, Y. Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats. Biological & Pharmaceutical Bulletin. 33: 836-843, 2010. DOI ScienceOn |
2 | Adessi, C., Frossard, M.-J., Boissard, C., Fraga, S., Bieler, S., Ruckle, T., Vilbois, F., Robinson, S. M., Mutter, M., Banks, W. A., Soto, C. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J. Biol. Chem. 278: 13905-13911, 2003. DOI ScienceOn |
3 | Feng, B.Y., Toyama, B.H., Wille, H., Colby, D.W., Collins, S. R., May, B.C.H., Prusiner, S.B., Weissman, J., Shoichet, B.K. Small-molecule aggregates inhibit amyloid polymerization. Nat. Chem. Biol. 4: 197-199, 2008. DOI ScienceOn |
4 | Necula, M., Kayed, R., Milton, S., Glabe, C.G. Small molecule inhibitors of aggregation indicate that amyloid b oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282: 10311-10324, 2007. DOI ScienceOn |
5 | Matthew, B.i., Shohei, K. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochimica et Biophysica Acta 1804: 1405-1412, 2010 DOI ScienceOn |
6 | Mahiuddin, A., Judianne, D., Darryl, A., Takeshi, S., Shivani, A., Saburo, A., James, I.E., William, E.V. & Steven, O.S. Structural conversion of neurotoxic amyloid-1-42 oligomers to fibrils. Nature Structural. and Molecular bio. 17: 561-567, 2010. DOI ScienceOn |
7 | Barrow, C.J., Yasuda, A., Kenny, P.T., Zagorski, M.G. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225: 1075-1093, 1992. DOI |
8 | Datki, Z., Juhasz, A., Galfi, M., Soós, K., Papp, R., Zadori, D., Penke, B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res Bull. 62: 223-229, 2003. DOI ScienceOn |
9 | 國家中醫藥管理局. 中華本草(第8卷). 上海: 上海科學技術出版社, pp 472-478, 1999. |
10 | Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., Wals, P., Zhang, C., Finch, C.E., Krafft, G.A., Klein, W.L. Diffusible, nonfibrillar ligands derived from Ab1-42 are potent contral nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95: 6448-6453, 1998. DOI ScienceOn |
11 | Klein, W.L., Krafft, G.A., Finch, C.E. Targeting small Ab oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24: 219-224, 2001. DOI ScienceOn |
12 | Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., Selkoe, D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long term potentiation in vivo. Nature 416: 535-539, 2002. DOI ScienceOn |
13 | 전국한의과대학 공동교재편찬위원회, 본초학, 영림사, pp 563-564, 2011 |
14 | Tjernberg, L.O., Naslund, J., Lindqvist, F., Johanson, J., Karlstrom, A.R., Thyberg, J., Terenius, L., Nordstedt, C. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271: 8545-8548, 1996. DOI ScienceOn |
15 | Findeis, M.A. Approaches to discovery and characterization of inhibitors of amyloid b-peptide polymerization. Biochim. Biophys. Acta 1502: 76-84, 2000. DOI ScienceOn |
16 | Talaga, P. beta-Amyloid aggregation inhibitors for the treatment of Alzheimer's disease: dream or reality? Mini Rev. Med. Chem. 1: 175-186, 2001. DOI ScienceOn |
17 | Selkoe, D.J. Alzheimer's disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140: 627-638, 2004. DOI ScienceOn |
18 | Permanne, B., Adessi, C., Fraga, S., Frossard, M.J., Saborio, G.P., Soto, C. Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease? J. Neural Transm. Suppl. 62: 293-301, 2002. DOI ScienceOn |
19 | Morrison, J.H., Hof, P.R. Life and death of neurons in the aging brain. Science 278: 412-419, 1997. DOI ScienceOn |
20 | Fraser, P.E., Lévesque, L., McLachian, D.R. Biochemistry of Alzheimer's disease amyloid plaques. Clin. Biochem. 26:339-349, 1993. DOI ScienceOn |
21 | Checler, F. Processing of the b-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65: 1431-1444, 1995. |
22 | Davies, P., Maloney, A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 308: 1403, 1976. |
23 | Stefani, M., Dobson, C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81: 678-699, 2003. DOI ScienceOn |
24 | Chiti, F., Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75: 333-366, 2006. DOI ScienceOn |